KPJ HEALTHCARE BHD
KLSE (MYR): KPJ (5878)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
1.13
Today's Change
+0.01 (0.89%)
Day's Change
1.11 - 1.13
Trading Volume
1,842,100
Financial
T4Q
31-Mar-2021
2020
31-Mar-2021
2019
31-Mar-2021
2018
31-Mar-2021
2017
31-Mar-2021
Discussions
4 people like this. Showing 50 of 1,805 comments
do something la board kpj yg baru..malula klu harga offer tuk esos staff pun dibawah nilai
2022-05-28 17:37
Kpj used to buy back own shares. Now duit tada.
The present BOD looks like a microcosm of our Cabinet Ministers
2022-06-17 14:58
Too many parasites we need to feed in our country . All BOD is empty brain with full money in pocket . Just like our Ex Prarasana Chairman
2022-06-18 14:48
For two over months now,no one wish to comment anything,why?Is this a sleeping counter?
2022-09-12 11:23
>Rambutan9
This stock behaves like a GLC because its owned by a Sultan. They (the royal family) will have some influence to get themselves into advantageous positions before it starts to move.
2022-09-12 16:23
A better-than-expected recovery in patient volume and operational efficiency is bolstering KPJ Healthcare Bhd's prospects, even as it comes off a stellar set of financial results.
KPJ reported a core profit after tax and minority interest (Patami) of RM54.6mil in Q3, which was double that of the immediate preceding quarter.
The healthcare group declared an interim dividend of one sen, going ex on Dec 12, 2022, as compared with a payout of 0.3 sen in the same quarter last year.
According to Hong Leong Investment Bank (HLIB) Research, the results were above its and consensus expectations at 95% of full-year forecasts.
2022-11-24 14:14
"The stellar results were achieved mainly due to stronger-than-expected recovery in hospital operations post-pandemic.
"We raise our FY22-24f earnings forecasts by 20-36%, to better reflect the strong rebound in patient volume and operational efficiency," said the research firm in a note.
It reiterated its "buy" call on KPJ while raising its target price to RM1.27 from RM1.13 previously.
2022-11-24 14:14
"The debt repayment is expected to lower KPJ’s net gearing to 0.61x, from 0.68x. The proposed sale is expected to complete by 1Q23," said HLIB.
In a separate report, CGS-CIMB Research noted that patient volume and bed occupancy rates have surpassed even pre-pandemic levels, possibly owing to underlying demand and pent-up demand from patients who had deferred surgeries during the COvid lockdowns.
"Post-3Q22 results, we raise FY22-24 forecast core earnings per share by 8.6-27.4%, mainly to factor in lower opex and depreciation, as well as higher associates earnings.
"We raise our FY22-24F payout ratio assumption to 70%, leading to yields of 2.5-3%.
"Our target price rises to RM1.18, after our earnings upgrade and rolling over to 2024 forecast price-earnings of 32 times (still 10-year mean)," it added.
2022-11-24 14:14
Wrong question!
Any high quality doctors there?
Currently many are being doctors for the status and remuneration without knowing the work of a doctor.
2023-01-01 13:27
Through my own experience, never trust a doctor 100%, because they are human too.
Avoid abusing our own health is the best medicine and prevention from falling sick.
2023-01-01 13:52
Government hospitals now lack manpower and good service. Private hospitals like this one, with a huge private sector base (this being on panels of most multinationals and GLCs), should do well by default.
1 month ago
First target for me is RM1.145, if hit, means can go higher after retrace.
1 month ago
KPJ Healthcare reports over 3-fold profit jump in 4Q
https://www.thestar.com.my/business/business-news/2023/02/17/kpj-healthcare-reports-over-3-fold-profit-jump-in-4q
1 month ago
Reiterate Add with a 12% higher TP of RM1.32
We raise FY23F/24F core EPS by 18%/16% to factor in lower opex and other
housekeeping adjustments post-FY22 results. Following our earnings upgrade, we raise
KPJ’s TP by 12% to RM1.32, based on an updated CY24F P/E of 31x (10-year mean, vs.
32x previously). While share price rose 34% from its 1-year low at end-Sep 22, its FY23F
P/E of 26.2x is still 17% (0.5 s.d.) below its 10-year historical mean. Potential re-rating
catalysts: full earnings recovery, rising health tourism contributions and improving ROIC.
Key downside risks: severe Covid-19 waves and longer gestation for its new hospitals.
CgsCimb 18/2/2023
1 month ago
Institutional buying mostly, buyers' market. TP1.25 should be in hand within next week, quickest this week
1 month ago
When qr out, a lot of people buy and somehow there are people press down the price, why? There must be something fishy
1 month ago
Nothing fishy la, its normal for investors and traders to take profit after such a big run. It also means you get a chance to buy or add more.
1 month ago
keep price low to buy up all the shares. that's JCorps plan via a GO later. looooong term hold
1 month ago
@Thankcarefully is right, but unfortunately people love to trade on rumour rather than facts. Anyway need to thank these people for selling low then buying back at high price.
1 month ago
Post a Comment
Featured Posts
10年前的手机革命造就了智能手机；10年后的今天，汽车革命会不会造就电动车？
MQ Trader - Introduction to MQ Trader Affiliate Program
I3investor - Meet the new I3investor...
Trending Events
Apps
Top Articles
1
Koon Yew Yin's Blog
2
Stock Pick Contest Year 2023
3
AmInvest Research Reports
4
Koon Yew Yin's Blog
PM Anwar’s visit to boost KL-Beijing strategic ties - Koon Yew Yin
5
Good Articles to Share
6
Good Articles to Share
7
Good Articles to Share
8
Good Articles to Share
Hot Stocks Today
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
maluapebossku
malu ape kpj? harge tak boleh naik...
2022-05-27 16:16